Published in Ann Intern Med on August 05, 2008
Mortality results from a randomized prostate-cancer screening trial. N Engl J Med (2009) 30.05
Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ (2010) 7.15
Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med (2013) 3.74
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer (2016) 2.91
Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol (2010) 2.89
Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst (2009) 2.84
Impact of comorbidity on survival among men with localized prostate cancer. J Clin Oncol (2011) 2.53
Prostate cancer screening: Canadian guidelines 2011. Can Urol Assoc J (2011) 2.50
Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion. J Clin Oncol (2012) 2.28
Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years. Radiat Oncol (2013) 2.26
Statin medications are associated with a lower probability of having an abnormal screening prostate-specific antigen result. Urology (2014) 2.09
Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare. J Am Geriatr Soc (2010) 2.08
Stereotactic body radiotherapy for organ-confined prostate cancer. BMC Urol (2010) 1.79
Prostate-specific antigen testing among the elderly in community-based family medicine practices. J Am Board Fam Med (2009) 1.76
Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation. Health Aff (Millwood) (2013) 1.63
Prostate specific antigen testing among the elderly--when to stop? J Urol (2009) 1.62
Calibrating disease progression models using population data: a critical precursor to policy development in cancer control. Biostatistics (2010) 1.42
Barbershop communications on prostate cancer screening using barber health advisers. Am J Mens Health (2010) 1.33
Challenging the 10-year rule: The accuracy of patient life expectancy predictions by physicians in relation to prostate cancer management. Can Urol Assoc J (2012) 1.32
Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening. Am J Hum Genet (2011) 1.26
Cancer screening in patients infected with HIV. Curr HIV/AIDS Rep (2011) 1.21
Call it cancer. Oncologist (2012) 1.18
Reducing PSA-Based Prostate Cancer Screening in Men Aged 75 Years and Older with the Use of Highly Specific Computerized Clinical Decision Support. J Gen Intern Med (2015) 1.17
Impact of cognitive impairment on screening mammography use in older US women. Am J Public Health (2010) 1.15
Risk stratification in prostate cancer screening. Nat Rev Urol (2012) 1.13
National evidence on the use of shared decision making in prostate-specific antigen screening. Ann Fam Med (2013) 1.11
Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies. J Urol (2014) 1.10
Simulation optimization of PSA-threshold based prostate cancer screening policies. Health Care Manag Sci (2012) 1.06
Patient-centered discussions about prostate cancer screening: a real-world approach. Ann Intern Med (2010) 1.05
Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group. Int J Cancer (2015) 1.04
Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls. Nat Clin Pract Endocrinol Metab (2009) 1.03
Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries. Arch Intern Med (2012) 0.99
Race/ethnicity and the perception of the risk of developing prostate cancer. Am J Prev Med (2009) 0.98
Increasing incidence of metastatic prostate cancer in the United States (2004-2013). Prostate Cancer Prostatic Dis (2016) 0.97
Optimization of PSA screening policies: a comparison of the patient and societal perspectives. Med Decis Making (2011) 0.96
Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes. Prostate (2013) 0.96
The cost implications of prostate cancer screening in the Medicare population. Cancer (2013) 0.95
Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada. Int J Cancer (2014) 0.94
Exploring patient perceptions of PSA screening for prostate cancer: risks, effectiveness, and importance. Can Fam Physician (2012) 0.94
Trends in prostate-specific antigen test use, 2000-2005. Public Health Rep (2011) 0.94
The impact of PSA testing frequency on prostate cancer incidence and treatment in older men. Prostate Cancer Prostatic Dis (2011) 0.93
Blood-based biomarkers of aggressive prostate cancer. PLoS One (2012) 0.92
Durable improvements in prostate cancer screening from online spaced education a randomized controlled trial. Am J Prev Med (2010) 0.91
Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases. BMC Cancer (2009) 0.91
PRE-VIEW: Development and Pilot Testing of An Interactive Video Doctor Plus Provider Alert to Increase Cancer Screening. ISRN Prev Med (2013) 0.89
Prostate cancer deaths and incident cases among American Indian/Alaska Native men, 1999-2009. Am J Public Health (2014) 0.89
Detection and isolation of circulating exosomes and microvesicles for cancer monitoring and diagnostics using micro-/nano-based devices. Analyst (2016) 0.89
Countries with high circumcision prevalence have lower prostate cancer mortality. Asian J Androl (2015) 0.88
Prostate cancer screening: Attitudes and practices of family physicians in Ontario. Can Urol Assoc J (2012) 0.88
Shared decision making, contextualized. Ann Fam Med (2013) 0.87
Factors affecting compliance with colorectal cancer screening among households residing in the largely Haitian community of Little Haiti, Miami-Dade County, Florida: an observational study. Medicine (Baltimore) (2015) 0.87
Are age-based criteria the best way to determine eligibility for prostate cancer screening? Ann Intern Med (2009) 0.86
Increased Dietary Inflammatory Index (DII) Is Associated With Increased Risk of Prostate Cancer in Jamaican Men. Nutr Cancer (2015) 0.86
Decision tree-based modeling of androgen pathway genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2011) 0.86
Emerging biomarkers of prostate cancer (Review). Oncol Rep (2012) 0.86
Risk of prostate cancer associated with benign prostate disease: a primary care case-control study. Br J Gen Pract (2011) 0.85
Determinants of participation in prostate cancer screening: a simple analytical framework to account for healthy-user bias. Cancer Sci (2014) 0.84
Prostate cancer screening and determining the appropriate prostate-specific antigen cutoff values. J Natl Compr Canc Netw (2010) 0.84
Association between smoking status, and free, total and percent free prostate specific antigen. J Urol (2012) 0.84
A new approach to understanding racial disparities in prostate cancer treatment. J Geriatr Oncol (2013) 0.84
Underuse of colorectal cancer screening among men screened for prostate cancer: a teachable moment? Cancer (2010) 0.83
Reduced Rate of Repeated Prostate Biopsies Observed in ConfirmMDx Clinical Utility Field Study. Am Health Drug Benefits (2014) 0.83
Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System. Prev Chronic Dis (2010) 0.82
Discussing uncertainty and risk in primary care: recommendations of a multi-disciplinary panel regarding communication around prostate cancer screening. J Gen Intern Med (2013) 0.82
Depression and coronary heart disease. ISRN Cardiol (2012) 0.82
Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes. J Urol (2014) 0.81
The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA. Nat Rev Urol (2016) 0.81
Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer. BMC Cancer (2015) 0.80
Shared decision making in prostate-specific antigen testing with men older than 70 years. J Am Board Fam Med (2013) 0.80
Patient selection essential in optimizing the benefit of radical prostatectomy for patients with organ-confined prostate cancer. Asian J Androl (2011) 0.80
A novel measure of dietary change in a prostate cancer dietary program incorporating mindfulness training. J Acad Nutr Diet (2012) 0.79
Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2015) 0.79
Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening. BMC Cancer (2011) 0.79
Are age-based criteria the best way to determine eligibility for prostate cancer screening? Ann Intern Med (2009) 0.79
Prostate cancer: PSA testing in older men--are we following the guidelines? Nat Rev Urol (2012) 0.79
Utilization of prostate cancer screening according to dietary patterns and other demographic variables. The adventist health study-2. J Cancer (2013) 0.79
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival. J Natl Cancer Inst (2017) 0.78
Associations of serum vitamin A and carotenoid levels with markers of prostate cancer detection among US men. Cancer Causes Control (2011) 0.78
Prostate cancer screening practices of African-American and non-African-American US primary care physicians: a cross-sectional survey. Int J Gen Med (2012) 0.78
What we have learned from randomized trials of prostate cancer screening. Asian J Androl (2011) 0.78
A structured implicit abstraction method to evaluate whether content of counseling before prostate cancer screening is consistent with recommendations by experts. Patient Educ Couns (2009) 0.78
Evaluation and Management of the Geriatric Urologic Oncology Patient. Curr Geriatr Rep (2015) 0.78
PSA-based prostate cancer screening: the role of active surveillance and informed and shared decision making. Asian J Androl (2011) 0.78
PSA screening for prostate cancer: why so much controversy? Asian J Androl (2013) 0.77
Prostate cancer screening trends in a large, integrated health care system. Perm J (2012) 0.77
How should prostate specific antigen be interpreted? Turk J Urol (2013) 0.77
Affecting African American men's prostate cancer screening decision-making through a mobile tablet-mediated intervention. J Health Care Poor Underserved (2014) 0.77
Prostate Cancer Screening Among American Indians and Alaska Natives: The Health and Retirement Survey, 1996-2008. Prev Chronic Dis (2015) 0.77
Abdominal and back pain in a 65-year-old patient with metastatic prostate cancer. J Chiropr Med (2010) 0.77
Prostate-specific antigen screening for prostate cancer: benefits for patients with highly aggressive prostate cancer. Asian J Androl (2013) 0.77
Lack of follow-up of prostate-specific antigen test results. Public Health Rep (2009) 0.76
Prostate cancer survivors' beliefs about screening and treatment decision-making experiences in an era of controversy. Psychooncology (2014) 0.76
Association of urinary phytoestrogen concentrations with serum concentrations of prostate-specific antigen in the National Health and Nutrition Examination Survey. Nutr Cancer (2013) 0.76
Prostate cancer screening and health care system distrust in Philadelphia. J Aging Health (2013) 0.76
Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey. J Cancer Educ (2016) 0.76
Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal. J Clin Endocrinol Metab (2010) 0.76
Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score. Cancer Med (2015) 0.76
Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 16.82
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 15.83
Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 11.96
Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 6.78
Screening for colorectal cancer: recommendation and rationale. Ann Intern Med (2002) 6.56
Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 6.26
Screening for prostate cancer: recommendation and rationale. Ann Intern Med (2002) 6.04
Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 6.01
Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann Intern Med (2011) 5.46
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med (2005) 5.24
Screening for breast cancer: recommendations and rationale. Ann Intern Med (2002) 4.90
The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 4.74
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med (2005) 4.66
Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2003) 4.55
Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. Ann Intern Med (2004) 4.52
Screening for obesity in adults: recommendations and rationale. Ann Intern Med (2003) 4.10
Screening for depression: recommendations and rationale. Ann Intern Med (2002) 3.88
Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 3.73
Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 3.65
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 3.64
Screening for abdominal aortic aneurysm: recommendation statement. Ann Intern Med (2005) 3.35
Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 3.27
Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 3.26
Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 3.11
Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit. Ann Intern Med (2007) 3.03
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med (2016) 3.02
Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med (2002) 2.98
Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med (2002) 2.95
Behavioral counseling in primary care to promote physical activity: recommendation and rationale. Ann Intern Med (2002) 2.94
Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 2.93
Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med (2009) 2.86
Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2015) 2.73
Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.57
Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.53
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 2.53
Screening for suicide risk in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.49
Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2007) 2.32
Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.20
Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med (2014) 2.16
Prevention of falls in community-dwelling older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 2.15
Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2009) 2.09
Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med (2015) 2.08
Breast cancer screening: from science to recommendation. Radiology (2010) 2.06
Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2009) 2.04
Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 2.03
Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 1.97
Aspirin for the primary prevention of cardiovascular events: recommendations and rationale. Am Fam Physician (2002) 1.95
Screening for High Blood Pressure in Adults: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med (2015) 1.94
Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.87
Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2008) 1.85
Screening for coronary heart disease: recommendation statement. Ann Intern Med (2004) 1.84
Chemoprevention of breast cancer: recommendations and rationale. Ann Intern Med (2002) 1.84
Screening for hepatitis B virus infection in nonpregnant adolescents and adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.83
Screening for type 2 diabetes mellitus in adults: recommendations and rationale. Ann Intern Med (2003) 1.81
Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2007) 1.75
The effectiveness of primary care-based interventions to promote breastfeeding: systematic evidence review and meta-analysis for the US Preventive Services Task Force. Ann Fam Med (2004) 1.72
Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2007) 1.71
Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.70
Screening for intimate partner violence and abuse of elderly and vulnerable adults: U.S. preventive services task force recommendation statement. Ann Intern Med (2013) 1.68
Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 1.63
Behavioral counseling to prevent skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 1.60
Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2012) 1.58
Screening for testicular cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2011) 1.56
Screening for hepatitis C virus infection in adults: recommendation statement. Ann Intern Med (2004) 1.56
Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 1.55
Screening for family and intimate partner violence: recommendation statement. Ann Fam Med (2004) 1.47
Primary care behavioral interventions to reduce illicit drug and nonmedical pharmaceutical use in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.47
Screening for hemochromatosis: recommendation statement. Ann Intern Med (2006) 1.44
Current processes of the U.S. Preventive Services Task Force: refining evidence-based recommendation development. Ann Intern Med (2007) 1.40
Screening for suicide risk: recommendation and rationale. Ann Intern Med (2004) 1.40
Lung cancer screening: recommendation statement. Ann Intern Med (2004) 1.38
Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 1.37
Screening for thyroid disease: recommendation statement. Ann Intern Med (2004) 1.36
Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med (2005) 1.31
Screening for gonorrhea: recommendation statement. Ann Fam Med (2005) 1.31
Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 1.30
Screening for chlamydial infection: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 1.29
Screening for carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2007) 1.28
Screening for syphilis infection: recommendation statement. Ann Fam Med (2004) 1.27
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med (2016) 1.27
Behavioral counseling interventions to promote a healthful diet and physical activity for cardiovascular disease prevention in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 1.26
Screening for asymptomatic bacteriuria in adults: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2008) 1.26
Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.25
Screening for cervical cancer: recommendations and rationale. Am J Nurs (2003) 1.25
Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 1.25
Screening for ovarian cancer: recommendation statement. Ann Fam Med (2004) 1.24
Behavioral counseling in primary care to promote a healthy diet: recommendations and rationale. Am J Prev Med (2003) 1.22
Medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 1.21
Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale. Ann Intern Med (2003) 1.21
Screening for visual impairment in children younger than age 5 years: recommendation statement. Ann Fam Med (2004) 1.20
Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 1.19
Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Pediatrics (2013) 1.19
Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 1.17
Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.15
Screening for dementia: recommendation and rationale. Ann Intern Med (2003) 1.14
Screening for oral cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.04
Screening for type 2 diabetes mellitus in adults: recommendations and rationale. Am J Nurs (2004) 1.04
Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale. Ann Intern Med (2002) 1.04
Screening for asymptomatic carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.02
Exercise tolerance testing to screen for coronary heart disease: a systematic review for the technical support for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 1.02